Balyasny Asset Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-51,816
| Closed | -$389K | – | 2892 |
|
|
2022
Q2 | $389K | Buy |
+51,816
| New | +$389K | ﹤0.01% | 1630 |
|
|
2021
Q4 | – | Sell |
-262,835
| Closed | -$3M | – | 2431 |
|
|
2021
Q3 | $3M | Buy |
+262,835
| New | +$3M | 0.01% | 818 |
|
|
2020
Q2 | – | Sell |
-197,844
| Closed | -$2.67M | – | 1424 |
|
|
2020
Q1 | $2.67M | Buy |
+197,844
| New | +$2.67M | 0.03% | 474 |
|
|
2019
Q4 | – | Sell |
-255,164
| Closed | -$4.9M | – | 1428 |
|
|
2019
Q3 | $4.9M | Buy |
+255,164
| New | +$4.9M | 0.03% | 487 |
|
|
2019
Q1 | – | Sell |
-35,611
| Closed | -$1.29M | – | 1605 |
|
|
2018
Q4 | $1.29M | Sell |
35,611
-286,572
| -89% | -$10.3M | 0.01% | 738 |
|
|
2018
Q3 | $19.8M | Sell |
322,183
-63,059
| -16% | -$3.88M | 0.09% | 270 |
|
|
2018
Q2 | $26M | Buy |
385,242
+328,442
| +578% | +$22.2M | 0.12% | 214 |
|
|
2018
Q1 | $3.08M | Sell |
56,800
-25,189
| -31% | -$1.37M | 0.01% | 717 |
|
|
2017
Q4 | $4.9M | Buy |
+81,989
| New | +$4.9M | 0.02% | 714 |
|
|
2015
Q4 | – | Sell |
-200,000
| Closed | -$3.55M | – | 1342 |
|
|
2015
Q3 | $3.55M | Buy |
+200,000
| New | +$3.55M | 0.03% | 470 |
|